US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Drug Discovery Market Research Reports & Industry Analysis

RSS Feeds

Drug Discovery Industry Research & Market Reports

6  7  8  9    11    13  14  15  
T Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2015
6/17/2015 | published by: BioSeeker Group AB
... cell receptor signaling. There are today 319 companies plus partners developing 404 T cell receptor pathway targeting drugs in 1601 developmental projects in cancer. In addition, there are 6 suspended drugs and the accumulated number ...  |  read more...
USD 6,750
Targeting Cell Adhesion Molecules (CAMs) for the Treatment of Cancer Drug Pipeline Update 2015
6/17/2015 | published by: BioSeeker Group AB
... biologic processes that include hemostasis, the immune response, inflammation, embryogenesis, and development of neuronal tissue. There are four main groups: the integrin family, the immunoglobulin superfamily, selectins, and cadherins. There are today 119 companies plus ...  |  read more...
USD 4,485
Targeting Focal Adhesion for the Treatment of Cancer Drug Pipeline Update 2015
6/17/2015 | published by: BioSeeker Group AB
... survival. At the cell-extracellular matrix contact points, specialized structures are formed and termed focal adhesions, where bundles of actin filaments are anchored to transmembrane receptors of the integrin family through a multi-molecular complex of junctional ...  |  read more...
USD 6,750
Targeting Natural Killer Cell Mediated Cytotoxicity in Cancer Drug Pipeline Update 2015
6/17/2015 | published by: BioSeeker Group AB
... and autologous cells undergoing various forms of stress, such as infection with viruses, bacteria, or parasites or malignant transformation. Although NK cells do not express classical antigen receptors of the immunoglobulin gene family, such as ...  |  read more...
USD 6,750
TGF-Beta Receptor Signaling Pathway in Oncology Drug Pipeline Update 2015
6/17/2015 | published by: BioSeeker Group AB
... in 1794 developmental projects in cancer. In addition, there are 2 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 261 drugs. Tgf-Beta Receptor Signaling Pathway In Oncology ...  |  read more...
USD 6,750
The MAPK Signaling Pathway in Oncology Drug Pipeline Update 2015
6/17/2015 | published by: BioSeeker Group AB
... There are today 315 companies plus partners developing 399 The MAPK signaling pathway targeting drugs in 1555 developmental projects in cancer. In addition, there are 2 suspended drugs and the accumulated number of ceased drugs ...  |  read more...
USD 6,750
TSH Signaling Pathway in Oncology Drug Pipeline Update 2015
6/17/2015 | published by: BioSeeker Group AB
... it will give signaling to NF-kappa B, mitogen activated protein kinases, protein kinase C modules. There are today 215 companies plus partners developing 294 TSH pathway targeting drugs in 1291 developmental projects in cancer. In ...  |  read more...
USD 6,750
NAPA/Procainamide: 2015 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations - France, Germany, Italy, Japan, Spain, UK, USA
6/4/2015 | published by: VPGMarketResearch.com
... Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories POC/Decentralized Testing - Physician Offices/Group Practices - Ambulatory Care Centers Please note: The delivery time for the electronic version of this report ...  |  read more...
USD 750
Amikacin: 2015 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations - France, Germany, Italy, Japan, Spain, UK, USA
6/4/2015 | published by: VPGMarketResearch.com
... Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories POC/Decentralized Testing - Physician Offices/Group Practices - Ambulatory Care Centers Please note: The delivery time for the electronic version of this ...  |  read more...
USD 750
Carbamazepine: 2015 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations - France, Germany, Italy, Japan, Spain, UK, USA
6/4/2015 | published by: VPGMarketResearch.com
... Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories POC/Decentralized Testing - Physician Offices/Group Practices - Ambulatory Care Centers Please note: The delivery time for the electronic version of this ...  |  read more...
USD 750
Gentamicin: 2015 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations - France, Germany, Italy, Japan, Spain, UK, USA
6/4/2015 | published by: VPGMarketResearch.com
... Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories POC/Decentralized Testing - Physician Offices/Group Practices - Ambulatory Care Centers Please note: The delivery time for the electronic version of this report ...  |  read more...
USD 750
Levetiracetam: 2015 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations - France, Germany, Italy, Japan, Spain, UK, USA
6/4/2015 | published by: VPGMarketResearch.com
... Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories POC/Decentralized Testing - Physician Offices/Group Practices - Ambulatory Care Centers Please note: The delivery time for the electronic version of this report ...  |  read more...
USD 750
Phenytoin: 2015 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations - France, Germany, Italy, Japan, Spain, UK, USA
6/4/2015 | published by: VPGMarketResearch.com
... Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories POC/Decentralized Testing - Physician Offices/Group Practices - Ambulatory Care Centers Please note: The delivery time for the electronic version of this report ...  |  read more...
USD 750
Valproic Acid: 2015 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations - France, Germany, Italy, Japan, Spain, UK, USA
6/4/2015 | published by: VPGMarketResearch.com
... Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories POC/Decentralized Testing - Physician Offices/Group Practices - Ambulatory Care Centers Please note: The delivery time for the electronic version of this ...  |  read more...
USD 750
Spasticity-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Spasticity Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Spasticity- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Spinal Stenosis-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Spinal Stenosis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Spinal Stenosis- Pipeline ...  |  read more...
USD 1,250
Spondylitis-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Spondylitis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Spondylitis- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Squamous Non-Small Cell Lung Cancer-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Squamous Non-Small Cell Lung Cancer Report helps to identify emerging players with potentially strong product information ...  |  read more...
USD 1,250
Steatohepatitis-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Steatohepatitis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Steatohepatitis- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Subacute Cutaneous Lupus Erythematosus (SCLE)-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Subacute Cutaneous Lupus Erythematosus (SCLE) Report helps to identify emerging players with potentially strong product information ...  |  read more...
USD 1,250
Systemic Juvenile Idiopathic Arthritis (SJIA)-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Systemic Juvenile Idiopathic Arthritis (SJIA) Report helps to identify emerging players with potentially strong product information ...  |  read more...
USD 1,250
Systemic Sclerosis (Scleroderma)-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Systemic Sclerosis (Scleroderma) Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Tardive Dyskinesia-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Tardive Dyskinesia Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Tardive Dyskinesia- Pipeline ...  |  read more...
USD 1,250
Tauopathies-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Tauopathies Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Tauopathies- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
T-Cell Leukemia-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The T-Cell Leukemia Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, T-Cell Leukemia- Pipeline ...  |  read more...
USD 1,250
6  7  8  9    11    13  14  15